REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS

甲型肝炎病毒的复制和衣壳抗原

基本信息

  • 批准号:
    3140133
  • 负责人:
  • 金额:
    $ 16.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-04-01 至 1993-11-30
  • 项目状态:
    已结题

项目摘要

Hepatitis A virus (HAV) causes one of the most prevalent infections of man, and remains a worldwide public health problem. The ability to propagate the virus in cultured cells, as well as the recent construction of cDNA clones and the determination of the nucleotide sequence of the viral genome, have made possible numerous new approaches to understanding the biology and pathogenesis of HAV infection and provided insight towards the development of potential subunit vaccines. In this application, we propose experiments designed to identify specific viral sequences that are responsible for the slow and protracted replication cycle of this virus, a characteristic that distinguishes it from all other members of its genus (enterovirus) and family (Picornaviridae). Recombinant viruses will be constructed that are composed of HAV 5' end regulatory sequences and poliovirus coding sequences, or HAV polymerase coding sequences replacing the homologous polio sequences. The efforts of the insertion of these potentially down-regulating HAV sequences into a rapidly-growing, lytic poliovirus will be evaluated by examining plaque size and morphology, temperature sensitivity, viral RNA and protein synthesis, and virus yields. Another uncharacterized HAV gene, the 2A protease coding region, will be analyzed for functions dealing with host cell interaction and virus morphogenesis by expressing genetically engineered proteins containing 2A sequences, both in vivo and in vitro. Finally, we have produced HAV capsid protein (VP1) antigens in both prokaryotic (E. coli) and eukaryotic (baculovirus-infected SF9) cells. We plan to systematically evaluate the ability of different antigenic proteins, expressed from a variety of different vectors and purified by different procedures, to induce neutralizing antibodies and/or to prime the immune system for a neutralizing anamnestic response. We hope that these studies will identify a recombinant protein that will be effective as a candidate immunogen for a subunit vaccine.
甲型肝炎病毒(HAV)是最普遍的病因之一

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Localization of priming epitope to the C-terminal portion of hepatitis A virus VP1.
甲型肝炎病毒 VP1 C 末端部分的引发表位定位。
  • DOI:
    10.1093/infdis/167.4.990
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Harmon,SA;Broman,B;Powdrill,TF;Johnston,JM;Ehrenfeld,E;Summers,DF
  • 通讯作者:
    Summers,DF
Replication of hepatitis A viruses with chimeric 5' nontranslated regions.
具有嵌合 5 非翻译区的甲型肝炎病毒的复制。
  • DOI:
    10.1128/jvi.70.5.2861-2868.1996
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jia,XY;Tesar,M;Summers,DF;Ehrenfeld,E
  • 通讯作者:
    Ehrenfeld,E
Expression of hepatitis A virus precursor protein P3 in vivo and in vitro: polyprotein processing of the 3CD cleavage site.
甲型肝炎病毒前体蛋白 P3 体内外表达:3CD 切割位点的多蛋白加工。
  • DOI:
    10.1006/viro.1994.1063
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Tesar,M;Pak,I;Jia,XY;Richards,OC;Summers,DF;Ehrenfeld,E
  • 通讯作者:
    Ehrenfeld,E
Host antibody response to viral structural and nonstructural proteins after hepatitis A virus infection.
甲型肝炎病毒感染后宿主抗体对病毒结构和非结构蛋白的反应。
  • DOI:
    10.1093/infdis/165.2.273
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jia,XY;Summers,DF;Ehrenfeld,E
  • 通讯作者:
    Ehrenfeld,E
Proteolytic activity of hepatitis A virus 3C protein.
甲型肝炎病毒3C蛋白的蛋白水解活性。
  • DOI:
    10.1128/jvi.65.5.2595-2600.1991
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Jia,XY;Ehrenfeld,E;Summers,DF
  • 通讯作者:
    Summers,DF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONALD F SUMMERS其他文献

DONALD F SUMMERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONALD F SUMMERS', 18)}}的其他基金

EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION
校外研究设施建设
  • 批准号:
    2286173
  • 财政年份:
    1994
  • 资助金额:
    $ 16.99万
  • 项目类别:
NUCLEIC ACID AND PROTEIN CORE FACILITY
核酸和蛋白质核心设施
  • 批准号:
    3522104
  • 财政年份:
    1993
  • 资助金额:
    $ 16.99万
  • 项目类别:
REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS
甲型肝炎病毒的复制和衣壳抗原
  • 批准号:
    3140128
  • 财政年份:
    1988
  • 资助金额:
    $ 16.99万
  • 项目类别:
REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS
甲型肝炎病毒的复制和衣壳抗原
  • 批准号:
    2063330
  • 财政年份:
    1988
  • 资助金额:
    $ 16.99万
  • 项目类别:
REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS
甲型肝炎病毒的复制和衣壳抗原
  • 批准号:
    2063328
  • 财政年份:
    1988
  • 资助金额:
    $ 16.99万
  • 项目类别:
REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS
甲型肝炎病毒的复制和衣壳抗原
  • 批准号:
    3140132
  • 财政年份:
    1988
  • 资助金额:
    $ 16.99万
  • 项目类别:
REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS
甲型肝炎病毒的复制和衣壳抗原
  • 批准号:
    3140130
  • 财政年份:
    1988
  • 资助金额:
    $ 16.99万
  • 项目类别:
REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS
甲型肝炎病毒的复制和衣壳抗原
  • 批准号:
    2063329
  • 财政年份:
    1988
  • 资助金额:
    $ 16.99万
  • 项目类别:
REPLICATION AND CAPSID ANTIGENS OF HEPATITIS A VIRUS
甲型肝炎病毒的复制和衣壳抗原
  • 批准号:
    3140131
  • 财政年份:
    1988
  • 资助金额:
    $ 16.99万
  • 项目类别:
COMPOSITION, ASSEMBLY AND REPLICATION OF RNA VIRUSES
RNA 病毒的组成、组装和复制
  • 批准号:
    3125159
  • 财政年份:
    1975
  • 资助金额:
    $ 16.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了